Octan uliprystalu (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Octan uliprystalu" in Polish language version.

refsWebsite

Global rank Polish rank

7doi.org

2^nd place

6^th place

7nih.gov

4^th place

7^th place

5europa.eu

68^th place

31^st place

2web.archive.org

1^st place

1princeton.edu

741^st place

1,921^st place

1cecinfo.org

low place

1ellaone.com

low place

1ec-ec.org

low place

1rcog.org.uk

low place

1fda.gov

447^th place

1,118^th place

1medscape.com

719^th place

1,030^th place

1nytimes.com

7^th place

29^th place

1watson.com

low place

cecinfo.org

ICEC: EC pill types and countries of availability, by brand. New York: International Consortium for Emergency Contraception (ICEC), 2014. [dostęp 2014-03-25].

doi.org

dx.doi.org

Mitchell D.M.D. Creinin Mitchell D.M.D. i inni, Progesterone receptor modulator for emergency contraception: a randomized controlled trial, „Obstetrics and Gynecology”, 108 (5), 2006, s. 1089–1097, DOI: 10.1097/01.AOG.0000239440.02284.45, PMID: 17077229, PMCID: PMC2853373 .
Anna F.A.F. Glasier Anna F.A.F. i inni, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis, „The Lancet”, 375 (9714), 2010, s. 555–562, DOI: 10.1016/S0140-6736(10)60101-8, PMID: 20116841 .
CarolineC. Moreau CarolineC., JamesJ. Trussell JamesJ., Results from pooled Phase III studies of ulipristal acetate for emergency contraception, „Contraception”, 86 (6), 2012, s. 673–680, DOI: 10.1016/j.contraception.2012.05.012, PMID: 22770793, PMCID: PMC3766836 .
Lynnette K.L.K. Nieman Lynnette K.L.K. i inni, Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study, „Fertility and Sterility”, 95 (2), 2011, 767–772.e1–2, DOI: 10.1016/j.fertnstert.2010.09.059, PMID: 21055739, PMCID: PMC4180231 .
Eric D.E.D. Levens Eric D.E.D. i inni, CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial, „Obstetrics and Gynecology”, 111 (5), 2008, s. 1129–1136, DOI: 10.1097/AOG.0b013e3181705d0e, PMID: 18448745, PMCID: PMC2742990 .
JacquesJ. Donnez JacquesJ. i inni, Ulipristal acetate versus placebo for fibroid treatment before surgery, „The New England Journal of Medicine”, 366 (5), 2012, s. 409–420, DOI: 10.1056/NEJMoa1103182, PMID: 22296075 .
Barbara J.B.J. Attardi Barbara J.B.J. i inni, In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone, „The Journal of Steroid Biochemistry and Molecular Biology”, 88 (3), 2004, s. 277–288, DOI: 10.1016/j.jsbmb.2003.12.004, PMID: 15120421 .

ec-ec.org

ECEC: Emergency contraception availability in Europe. New York: European Consortium for Emergency Contraception (ECEC), 2014. [dostęp 2014-03-25]. Cytat: Ulipristal acetate Emergency Contraception Pills (UPA ECPs), while available in most European countries since 2010, are not yet available in Albania, Estonia, Macedonia, Malta, Switzerland and Turkey. For now UPA ECPs are sold with a prescription in all countries, although provision without a prescription is currently being tested in the United Kingdom..

ellaone.com

HRA Pharma: Countries where ellaOne was launched. Paris: HRA Pharma, 2013-03. [dostęp 2014-03-25].

europa.eu

ema.europa.eu

Summary of Product Characteristics: ellaOne 30 mg tablet. [dostęp 2010-11-20].
European Public Assessment Report for Ellaone. Summary for the public, EMA, 2009, s. 2 [dostęp 2009-11-22] .
European Medicines Agency – News and Events – EMA recommends availability of ellaOne emergency contraceptive without prescription [online], www.ema.europa.eu [dostęp 2017-11-19] (ang.).
Summary of Product Characteristics: Esmya 5mg tablet. [dostęp 2014-02-20].

ec.europa.eu

http://ec.europa.eu/health/documents/community-register/2015/20150107130448/dec_130448_en.pdf

fda.gov

Elaine Gansz Bobo: FDA approves ella™ tablets for prescription emergency contraception. FDA. [dostęp 2015-01-18]. [zarchiwizowane z tego adresu (2011-02-10)]. (ang.).

medscape.com

Emma Hitt: FDA Panel Gives Ulipristal Acetate Unanimous Positive Vote for Emergency Contraception Indication. 2010-06-18. [dostęp 2010-06-22].

nih.gov

ncbi.nlm.nih.gov

Mitchell D.M.D. Creinin Mitchell D.M.D. i inni, Progesterone receptor modulator for emergency contraception: a randomized controlled trial, „Obstetrics and Gynecology”, 108 (5), 2006, s. 1089–1097, DOI: 10.1097/01.AOG.0000239440.02284.45, PMID: 17077229, PMCID: PMC2853373 .
Anna F.A.F. Glasier Anna F.A.F. i inni, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis, „The Lancet”, 375 (9714), 2010, s. 555–562, DOI: 10.1016/S0140-6736(10)60101-8, PMID: 20116841 .
CarolineC. Moreau CarolineC., JamesJ. Trussell JamesJ., Results from pooled Phase III studies of ulipristal acetate for emergency contraception, „Contraception”, 86 (6), 2012, s. 673–680, DOI: 10.1016/j.contraception.2012.05.012, PMID: 22770793, PMCID: PMC3766836 .
Lynnette K.L.K. Nieman Lynnette K.L.K. i inni, Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study, „Fertility and Sterility”, 95 (2), 2011, 767–772.e1–2, DOI: 10.1016/j.fertnstert.2010.09.059, PMID: 21055739, PMCID: PMC4180231 .
Eric D.E.D. Levens Eric D.E.D. i inni, CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial, „Obstetrics and Gynecology”, 111 (5), 2008, s. 1129–1136, DOI: 10.1097/AOG.0b013e3181705d0e, PMID: 18448745, PMCID: PMC2742990 .
JacquesJ. Donnez JacquesJ. i inni, Ulipristal acetate versus placebo for fibroid treatment before surgery, „The New England Journal of Medicine”, 366 (5), 2012, s. 409–420, DOI: 10.1056/NEJMoa1103182, PMID: 22296075 .
Barbara J.B.J. Attardi Barbara J.B.J. i inni, In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone, „The Journal of Steroid Biochemistry and Molecular Biology”, 88 (3), 2004, s. 277–288, DOI: 10.1016/j.jsbmb.2003.12.004, PMID: 15120421 .

nytimes.com

Gardiner Harris: F.D.A. Approves 5-Day Emergency Contraceptive. [w:] The New York Times [on-line]. 2010-08-14. [dostęp 2010-08-14].

princeton.edu

ec.princeton.edu

James Trussell, Kelly Cleland: Dedicated emergency contraceptive pills worldwide. Princeton: Office of Population Research at Princeton University, Association of Reproductive Health Professionals, 2013-02-13. [dostęp 2014-03-25].

rcog.org.uk

The Care of Women Requesting Induced Abortion. Evidence-based clinical guideline number 7, London: RCOG, 2004, ISBN 1-904752-06-3 [zarchiwizowane z adresu 2008-02-27] .

watson.com

ir.watson.com

Watson PR: Watson Launches ella(R)(ulipristal acetate). 2010-12-01. [dostęp 2015-02-18].

web.archive.org

The Care of Women Requesting Induced Abortion. Evidence-based clinical guideline number 7, London: RCOG, 2004, ISBN 1-904752-06-3 [zarchiwizowane z adresu 2008-02-27] .
Elaine Gansz Bobo: FDA approves ella™ tablets for prescription emergency contraception. FDA. [dostęp 2015-01-18]. [zarchiwizowane z tego adresu (2011-02-10)]. (ang.).